throbber
IOP PUBLISHING
`
`Physiol. Meas. 28 (2007) R1–R39
`
`PHYSIOLOGICAL MEASUREMENT
`
`doi:10.1088/0967-3334/28/3/R01
`
`TOPICAL REVIEW
`
`Photoplethysmography and its application in clinical
`physiological measurement
`
`John Allen
`
`Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
`
`E-mail: john.allen@nuth.nhs.uk
`
`Received 8 October 2006, accepted for publication 24 January 2007
`Published 20 February 2007
`Online at stacks.iop.org/PM/28/R1
`
`Abstract
`Photoplethysmography (PPG) is a simple and low-cost optical technique that
`can be used to detect blood volume changes in the microvascular bed of tissue.
`It is often used non-invasively to make measurements at the skin surface. The
`PPG waveform comprises a pulsatile (‘AC’) physiological waveform attributed
`to cardiac synchronous changes in the blood volume with each heart beat,
`and is superimposed on a slowly varying (‘DC’) baseline with various lower
`frequency components attributed to respiration, sympathetic nervous system
`activity and thermoregulation. Although the origins of the components of
`the PPG signal are not fully understood, it is generally accepted that they
`can provide valuable information about the cardiovascular system. There has
`been a resurgence of interest in the technique in recent years, driven by the
`demand for low cost, simple and portable technology for the primary care
`and community based clinical settings, the wide availability of low cost and
`small semiconductor components, and the advancement of computer-based
`pulse wave analysis techniques. The PPG technology has been used in a
`wide range of commercially available medical devices for measuring oxygen
`saturation, blood pressure and cardiac output, assessing autonomic function
`and also detecting peripheral vascular disease. The introductory sections of the
`topical review describe the basic principle of operation and interaction of light
`with tissue, early and recent history of PPG, instrumentation, measurement
`protocol, and pulse wave analysis. The review then focuses on the applications
`of PPG in clinical physiological measurements, including clinical physiological
`monitoring, vascular assessment and autonomic function.
`
`ageing, artery, autonomic function, blood pressure, cardiac
`Keywords:
`output, cardiovascular, diabetes, endothelial function, heart rate, infrared,
`microcirculation, photoplethysmography (PPG), pulse wave
`analysis,
`Raynaud’s phenomenon, vascular disease, vein
`
`0967-3334/07/030001+39$30.00 © 2007 IOP Publishing Ltd Printed in the UK
`
`R1
`
`Apple Inc.
`APL1021
`U.S. Patent No. 8,923,941
`
`FITBIT, Ex. 1021
`
`

`

`R2
`
`Topical Review
`
`1. Background to the topical review
`
`Photoplethysmography (PPG) is an optical measurement technique that can be used to detect
`blood volume changes in the microvascular bed of tissue (Challoner 1979). It has widespread
`clinical application, with the technology utilized in commercially available medical devices,
`for example in pulse oximeters, vascular diagnostics and digital beat-to-beat blood pressure
`measurement systems. The basic form of PPG technology requires only a few opto-electronic
`components: a light source to illuminate the tissue (e.g. skin), and a photodetector to measure
`the small variations in light intensity associated with changes in perfusion in the catchment
`volume. PPG is most often employed non-invasively and operates at a red or a near
`infrared wavelength. The most recognized waveform feature is the peripheral pulse, and it is
`synchronized to each heartbeat. Despite its simplicity the origins of the different components
`of the PPG signal are still not fully understood. It is generally accepted, however, that they
`can provide valuable information about the cardiovascular system (Kamal et al 1989).
`This review has two parts. An introductory section describes the basic principle of PPG
`operation, light interaction with tissue, early and recent history of PPG, instrumentation,
`measurement protocol, and pulse wave analysis. The second section reviews current and
`potential clinical applications in physiological measurement under the categories of clinical
`physiological monitoring, vascular assessment and autonomic function.
`
`2. Photoplethysmography
`
`2.1. The photoplethysmography waveform
`
`The pulsatile component of the PPG waveform is often called the ‘AC’ component and usually
`has its fundamental frequency, typically around 1 Hz, depending on heart rate (figure 1).
`This AC component is superimposed onto a large quasi-DC component that relates to the
`tissues and to the average blood volume. This DC component varies slowly due to respiration,
`vasomotor activity and vasoconstrictor waves, Traube Hering Mayer (THM) waves and
`also thermoregulation (Burton 1939, Burton and Taylor 1940, Hertzman and Dillon 1940b,
`Hertzman and Roth 1942a, 1942b, 1942c, Hertzman and Flath 1963, Hyndman et al 1971,
`Pe˜n´az 1978, Ahmed et al 1982, Harness and Marjanovic 1989, Nitzan et al 1996b, 1996a,
`general thermoregulatory pulse changes in Shusterman et al (1997), Schultz-Ehrenburg and
`Blazek (2001), Nitzan et al (2001)). These characteristics are also body site dependent (Allen
`and Murray 2000b). With suitable electronic filtering and amplification both the AC and DC
`can be extracted for subsequent pulse wave analysis.
`
`2.2. Optical considerations of the origins of the photoplethysmography waveform
`
`The interaction of light with biological tissue is complex and includes the optical processes
`of (multiple) scattering, absorption, reflection, transmission and fluorescence (Anderson and
`Parrish 1981). Several researchers have investigated the optical processes in relation to PPG
`measurements (Hertzman and Randall 1948, Brown et al 1965, D’Agrosa and Hertzman 1967,
`Weinman 1967, Zweifler et al 1967, Challoner 1979, Ochoa and Ohara 1980, Nijboer et al
`1981, Roberts 1982, Lindberg and ¨Oberg 1993, de Trafford and Lafferty 1984, Kamal et al
`1989). They have highlighted the key factors that can affect the amount of light received
`by the photodetector: the blood volume, blood vessel wall movement and the orientation of
`red blood cells (RBC). The orientation effect has been demonstrated by recording pulsatile
`waveforms from dental pulp and in a glass tube where volumetric changes should not be
`
`FITBIT, Ex. 1021
`
`

`

`Topical Review
`
`R3
`
`Figure 1. The pulsatile (AC) component of the PPG signal and corresponding electrocardiogram
`(ECG). The AC component is actually superimposed on a much larger quasi-DC component that
`relates to the tissues and to the average blood volume within the sample. It represents the increased
`light attenuation associated with the increase in microvascular blood volume with each heartbeat.
`In practice, the PPG waveform is often inverted.
`
`possible, and more recently by N¨aslund et al (2006) who detected pulsatile waveforms in
`bone. The recorded pulses do bear a direct relationship with perfusion, and the greater the
`blood volume the more the light source is attenuated. However, attempts at pulse amplitude
`quantification (‘calibration’) have been largely unsuccessful (Hertzman 1938, Challoner and
`Ramsay 1974, Jespersen and Pedersen 1986, Cejnar et al 1993).
`The wavelength of optical radiation is also important in light–tissue interactions (Cui et al
`1990), and for three main reasons: (1) The optical water window: the main constituent of
`tissue is water that absorbs light very strongly in the ultraviolet and the longer infrared
`wavelengths. The shorter wavelengths of light are also strongly absorbed by melanin. There
`is, however, a window in the absorption spectra of water that allows visible (red) and near
`infrared light to pass more easily, thereby facilitating the measurement of blood flow or
`volume at these wavelengths. Thus, the red or near infrared wavelengths are often chosen
`for the PPG light source (Jones 1987), (2) Isobestic wavelength: significant differences exist
`in absorption between oxyhaemoglobin (HbO2) and reduced haemoglobin (Hb) except at
`the isobestic wavelengths (Gordy and Drabkin 1957). For measurements performed at an
`isobestic wavelength (i.e. close to 805 nm, for near infrared range) the signal should be largely
`unaffected by changes in blood oxygen saturation, and (3) Tissue penetration depth: the depth
`to which light penetrates the tissue for a given intensity of optical radiation depends on the
`operating wavelength (Murray and Marjanovic 1997). In PPG the catchment (study) volume,
`depending on the probe design, can be of the order of 1 cm3 for transmission mode systems.
`PPG can provide information about capillary nutritional blood flow and the thermoregulatory
`blood flow through arterio-venous anastomosis shunt vessels.
`
`2.3. Early and recent history of photoplethysmography
`
`This paragraph gives a brief summary of the early history of PPG and is taken from the
`excellent review article by Challoner (1979).
`In 1936 two research groups (Molitor and
`Kniazuk of the Merck Institute of Therapeutic Research, New Jersey, and Hanzlik et al of
`Stanford University School of Medicine) described similar instruments used to monitor the
`blood volume changes in the rabbit ear following venous occlusion and with administration
`of vasoactive drugs. Molitor and Kniazuk also described recordings made with a reflection
`mode PPG system from human fingers. A pioneer who helped establish the PPG technique
`was Alrick Hertzman from the Department of Physiology at St. Louis University School of
`
`FITBIT, Ex. 1021
`
`

`

`R4
`
`Topical Review
`
`Medicine, St. Louis, MO. In 1937, Hertzman and his colleagues published their first paper
`on PPG describing the use of a reflection mode system to measure blood volume changes
`in the fingers induced by the Valsalva manoeuvre, exercise and with exposure to cold. This
`excellent contribution to the field demonstrated the potential clinical utility of the technique.
`In 1938, Hertzman undertook a validation of the PPG technique by comparing blood volume
`changes with those measured simultaneously by mechanical plethysmography. Preliminary
`observations on the PPG technique were also reported in the same year by Matthes and
`Hauss. Hertzman and Dillon (1940a) split the AC and DC components with separate electronic
`amplifiers and monitored vasomotor activity. Potential sources of error with the technique have
`been identified by Hertzman (1938), who emphasized that good contact with skin was needed,
`but without excessive pressure that would result in blanching. He advised that movement
`of the measurement probe against the skin should be avoided. These observations led to the
`development of elaborate positioning devices. Illumination was identified as another important
`design consideration. Hertzman also used a battery powered torch bulb which was less than
`ideal because of its relatively wide spectrum, particularly in the infrared because of local tissue
`heating, errors due to the effects of oxygen saturation, and the widespread illumination which
`can mix skin microvascular blood flow with larger vessel signals. Furthermore, constant light
`intensity could not be guaranteed.
`In more recent decades the desire for small, reliable, low-cost and simple-to-use non-
`invasive (cardiovascular) assessment techniques are key factors that have helped re-establish
`photoplethysmography. Advances in opto-electronics and clinical instrumentation have also
`significantly contributed to its advancement. The developments in semiconductor technology,
`i.e. light emitting diodes (LED), photodiodes and phototransistors, have made considerable
`improvements in the size, sensitivity, reliability and reproducibility of PPG probe design. A
`major advance in the clinical use of a PPG-based technology came with the introduction of the
`pulse oximeter as a non-invasive method for monitoring patients’ arterial oxygen saturation
`(Aoyagi et al 1974, Yoshiya et al 1980). There have also been considerable developments in
`computer-based digital signal processing and pulse wave analysis.
`
`2.4. Photoplethysmography instrumentation
`
`Modern PPG sensors often utilize low cost semiconductor technology with LED and matched
`photodetector devices working at the red and/or near infrared wavelengths (CIE IR-A near
`infrared band 0.8 to 1 μm, Duck (1990)). An excellent review of optical sensor technology
`for PPG and pulse oximetry applications is written by Webster (1997).
`(cid:2)(cid:2)
`berg
`The choice of light source is important (Burke and Whelan 1986, Lindberg and O
`1991, Ugnell and ¨Oberg 1995). LEDs convert electrical energy into light energy and have a
`narrow single bandwidth (typically 50 nm). They are compact, have a very long operating
`life (>105 h), operate over a wide temperature range with small shifts in the peak-emitted
`wavelength, and are mechanically robust and reliable. The averaged intensity of the LED
`should be constant and preferably be sufficiently low to minimize excessive local tissue heating
`and also reduce the risk of a non-ionizing radiation hazard. The choice of photodetector is
`also important (Weinman and Fine 1972, Fine and Weinman 1973). Its spectral characteristics
`are chosen to match that of the light source. A photodetector converts light energy into an
`electrical current. They are compact, low-cost, sensitive, and have fast response times. Near
`infrared devices can be encased with daylight filters. The photodetector connects to low noise
`electronic circuitry that includes a transimpedance amplifier and filtering circuitry.
`A high pass filter reduces the size of the dominant DC component and enables the
`pulsatile AC component to be boosted to a nominal 1 V peak-to-peak level. Carefully
`
`FITBIT, Ex. 1021
`
`

`

`Topical Review
`
`R5
`
`(a)
`
`(b)
`
`Figure 2. Electronic building blocks used in a typical PPG measurement system.
`(a) A
`transimpedance (current-to-voltage) amplifier stage that converts light intensity at the photodiode
`(PD) to an amplifier output voltage (V = I × R, transimpedance gain proportional to feedback
`resistor value R). (b) The signal conditioning stages surrounding the transimpedance amplifier
`which include low pass filtering, high pass filtering and further amplification, inversion and signal
`interfaces. The AC component and a measure of the DC component are available for pulse wave
`analysis. A constant current driver stage for the PPG LED is also shown.
`
`chosen filtering circuitry is also needed to remove the unwanted higher frequency noise such
`as electrical pick up from (50 Hz) mains electricity frequency interference. Figure 2(a)
`shows a transimpedance amplifier design and figure 2(b) shows the signal conditioning stages
`surrounding this, including low pass filtering, high pass filtering and further amplification,
`signal inversion and signal interface. The choice of high pass filter cut-off frequency is
`particularly important and is often a design compromise; excessive filtering can distort the
`pulse shape but too little filtering can result in the quasi-DC component dominating over the
`AC pulse (Allen and Murray 2003, 2004). This example system shows a constant current
`driver stage for the PPG probe LED.
`There are two main PPG operational configurations: transmission (‘trans-illumination’)
`mode operation where the tissue sample (e.g. fingertip) is placed between the source and
`detector, and reflection (‘adjacent’) mode operation where the LED and detector are placed
`side-by-side. Clearly, transmission mode PPG imposes more restrictions than the reflection
`mode PPG on the body locations available for study. The PPG probe should be held securely
`in place to minimize probe-tissue movement artefact. There are other sources of artefact that
`need to be considered in the measurement technology. For example, artefact can arise from
`ambient light interference but can be reduced in several ways: by suitable probe attachment
`to the skin (e.g. using a dark Velcro wrap-around cuff), by further shading of the study site
`area and performing measurements in subdued lighting, and by electronic filtering (e.g. light
`modulation filtering, Webster (1997)). Ambient light interference in PPG-based systems has
`also been discussed by Hanowell et al (1987).
`Many of the studies reported in the PPG literature are for a single site, often the ear, finger
`or toe, where pulses can easily be detected (including Stern (1974), Barnes et al (1977a, 1977b),
`Sherebrin and Sherebrin (1990), Allen and Murray (1993), Chowienczyk et al (1999), Hahn
`et al (1999), Bortolotto et al (2000), Foo et al (2006), Millasseau et al (2006)). Many other
`skin measurement sites are available for vascular assessment (Tur et al 1983). The supraorbital
`
`FITBIT, Ex. 1021
`
`

`

`R6
`
`Topical Review
`
`artery, just above each eye has been studied (Lee et al 1981), as well as measurements on the
`skin above key arterial landmarks (Loukogeorgakis et al 2002). There have also been studies
`published which investigated PPG pulses at two sites simultaneously (Dillon and Hertzman
`1941, Nijboer and Dorlas 1985, Cooke et al 1985, Grossmann et al 1987, Okada et al 1986,
`Porret et al 1995, Nitzan et al 1998b, 1998a, 2001). Three channel PPG research systems
`have been described by Evans and Geddes (1988) and four channel research systems by Buchs
`et al (2005) and Erts et al (2005). Multiple finger site pulse data have also been reported by
`Dyszkiewicz and Tendera (2006). Six channel PPG data have been published for simultaneous
`multi-bilateral site PPG data measurements (i.e. the right and left ear lobes, index fingers or
`thumbs, and great toes) (Allen et al 2000, 2002, 2003, 2004, 2005, 2006). Technically, Allen
`and Murray (2000a) have emphasized the importance of the electronic and optical matching of
`pulse amplifier channels to allow the best chance for right-to-left side physiological differences
`to be detected with confidence. A multi-bilateral site PPG pulse measurement and analysis
`system and example pulse recording from a healthy subject are shown in figure 3. PPG systems
`are also available commercially. Examples include the Skidmore Medical Ltd. Vicorder, the
`Cuban Biof´ısica M´edica ANGIODIN R(cid:3)
`PD 3000, and the VIASYS Healthcare MicroLiteTM
`and VasoGuardTM systems. These lists are not exhaustive.
`Other emerging technologies include PPG imaging technology, telemedicine and remote
`monitoring.
`Schultz-Ehrenburg and Blazek (2001) and Huelsbusch and Blazek (2002)
`investigated an experimental cooled near infrared CCD PPG imaging system for studying
`skin blood flow and related rhythmical phenomena. The aim of the technology was to obtain
`new insights into normal physiological tissue perfusion and detect changes associated with
`ulcer formation and wound healing. In 2005, Wieringa et al described a contactless multiple
`wavelength PPG imaging system whose main application is the remote imaging of arterial
`oxygen saturation (SpO2) distribution within tissue. The system acquires movies of two-
`dimensional matrix spatially resolved PPG signals at three wavelengths (660 nm, 810 nm
`and 940 nm) during changes in respiration. A tissue oxygen image might be useful in
`many areas of medical diagnostics, for example in quantifying tissue viability. PPG has
`considerable potential for telemedicine including the remote/home health monitoring of
`patients. Miniaturization, ease-of-use and robustness are key design requirements for such
`systems. This is illustrated with finger ring-based PPG sensors for monitoring beat-to-beat
`pulsations (Rhee et al 2001, Zheng and Zhang 2003) and the need for motion artefact reduction,
`optimal sensor placement and minimizing battery power consumption. Innovative LED and
`photodetector array technology has been incorporated into a PPG finger sensor and palm-sized
`home health monitor to enable the pulse, oxygen saturation and respiration to be measured
`along with haematocrit derived from optical characteristics at five different wavelengths (569,
`660, 805, 904 and 975 nm) (Yoon et al 2005). Preliminary clinical testing showed that
`the haematocrit was within ±10% of the gold standard value. Respiratory information was
`extracted using digital filtering techniques and blood oxygen saturation (SpO2) predicted using
`the standard ratio for the red and near infrared wavelengths.
`
`2.5. Measurement protocol and reproducibility
`Reproducibility is very important in clinical physiological measurement, for example in giving
`confidence in detecting significant responses to therapy. Many factors affect reproducibility,
`including the method of probe attachment to tissue, probe–tissue interface pressure, pulse
`amplifier bandwidth, minimization of movement artefact, subject posture and relaxation,
`breathing, wakefulness, room temperature and acclimatization (Teng and Zhang 2006, Zhang
`and Zhang 2006). As yet, however, there are no internationally recognized standards for
`clinical PPG measurement. Published research tends to be based on studies using quite
`
`FITBIT, Ex. 1021
`
`

`

`Topical Review
`
`(a)
`
`R7
`
`(b)
`
`Figure 3. Multi-bilateral site photoplethysmography.
`(a) An overview of a six channel PPG
`measurement and analysis system, giving capability for pulses to be compared between the right
`and left sides and between head to foot sites (Allen et al 2006). (b) An example recording made
`from the right and left ear lobes, index fingers, and great toes of a healthy subject. There is similarity
`in the pulse characteristics between the right and left body sides but clear differences between the
`proximal and distal measurement sites. However, the degree of right to left side similarity in the
`high and low frequency components of the PPG waveform can be reduced in patients with vascular
`disease (Allen and Murray 2000a) and also in patients with autonomic dysfunction (Buchs et al
`2005).
`
`FITBIT, Ex. 1021
`
`

`

`R8
`
`Topical Review
`
`differing measurement technology and protocols, thereby limiting the ease with which PPG
`physiological measurements can be replicated between research centres.
`There are a limited number of studies quantifying the repeatability or reproducibility of
`PPG measurements. An important study by Jago and Murray (1988) addressed the uncertainty
`in PPG measurements for a group of healthy adult subjects. They studied the repeatability of
`PPG pulse transit time (PTT) measurements made from the ear, thumb and toe sites both within
`session and between sessions held on separate days. Measurements at individual sites and
`bilateral (right–left) side differences were both assessed. The results showed the importance of
`controlling for factors such as posture, ambient temperature, relaxation and acclimatization.
`Bilateral measurements were generally more repeatable than individual site measurements
`since heart rate, respiration and blood pressure factors tend to affect both sides of the body
`simultaneously.
`There have also been a limited number of studies published that quantify the complex
`physiological variability in PPG waveforms measured at different body sites. Applications that
`utilize the beat-to-beat variation in PPG characteristics include the assessment of autonomic
`dysfunction and cardiovascular ageing (see section 3.3). It can also be useful, however, to
`obtain an averaged pulse measure to represent an individual subject/site. An averaging period
`covering at least 60 heartbeats has been suggested to improve confidence in the single timing,
`amplitude or shape measurements extracted from the PPG pulse (Allen 2002).
`
`2.6. Photoplethysmography pulse wave characterization and analysis
`
`2.6.1. Pulse wave characterization. Two important characteristics of the PPG AC pulse
`waveform were described by Hertzman and Spealman (1937). The appearance of the pulse
`was defined as two phases: the anacrotic phase being the rising edge of the pulse, and the
`catacrotic phase being the falling edge of the pulse. The first phase is primarily concerned
`with systole, and the second phase with diastole and wave reflections from the periphery. A
`dicrotic notch is usually seen in catacrotic phase of subjects with healthy compliant arteries.
`It is useful also to consider the blood pressure pulse and its propagation along individual
`arteries. The pressure pulse wave is known to change in shape as it moves toward the periphery
`and undergoes amplification and alterations in its shape and temporal characteristics. These
`changes are thought to be largely due to reflection of the pulse wave and the tapering down
`of the arteries towards the periphery. Pulse propagation in arteries is further complicated by
`frequency dependent phase distortion. These phenomena have been described by O’Rourke
`and Gallagher (1996) and are discussed in the wider literature on pulse. The blood pressure
`pulse has similarities with the PPG blood volume pulse, with similar changes occurring in
`vascular disease, such as damping and a loss of pulsatility. The damping has been associated
`with a reduction in vessel compliance and increased peripheral resistance, although these
`changes have yet to be fully explained.
`The potential of PPG for assessing vascular disease was recognized many decades ago. In
`1940b, Hertzman and Dillon compared PPG to mechanical plethysmography in arteriopaths
`and in normal control subjects. They derived a crest time measurement from the rising edge
`of the pulse waveform and normalized this to the heart rate. The crest time was prolonged
`in patients with vascular disease or hypertension. The potential for extracting diagnostic
`information from the PPG pulse has been reviewed by Murray and Foster (1996). From the
`literature, many features have been investigated (figure 4), including beat-to-beat PPG rise
`time, PTT, amplitude, shape, and the variability in each of these. The pulse shape (contour)
`can also be described after normalization in pulse width and height (Allen and Murray 2003).
`
`FITBIT, Ex. 1021
`
`

`

`Topical Review
`
`(a)
`
`R9
`
`(b)
`
`1.2
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`1.2
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`20
`
`40
`
`60
`
`80
`
`100
`
`20
`
`40
`
`60
`
`80
`
`100
`
`20
`
`40
`
`60
`
`80
`
`100
`
`1.2
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`1.2
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`1
`
`0.8
`
`0.6
`
`0.4
`
`0.2
`
`0
`
`0
`
`20
`
`40
`
`60
`
`80
`
`100
`
`20
`
`40
`
`60
`
`80
`
`100
`
`20
`
`40
`
`60
`
`80
`
`100
`
`Figure 4. Characterization of PPG pulse timing, amplitude and shape features. (a) Key pulse
`landmarks can automatically be identified using a pulse wave analysis computer to give beat-to-
`beat pulse transit time to the foot of the pulse (PTTf), pulse transit time to the peak of the pulse
`(PTTp), and foot-to-peak amplitude (AMP). The pulse landmarks can then be used to calculate
`the normalized pulse contour. Contour examples are given in (b) for two different healthy subjects
`(Allen and Murray 2003).
`
`FITBIT, Ex. 1021
`
`

`

`R10
`
`Topical Review
`
`(a)
`
`(b)
`
`(c)
`
`(d)
`
`Figure 5. Examples of the types of measurement artefact and the extremes in physiological
`variation that can be seen in PPG recordings. Each recording is from the index finger site over a
`period of 1 min and the artefact/physiological events are marked. (a) An episode of gross movement
`artefact or PPG probe cable tugging lasting approximately 15 s. (b) Hand or finger tremor, (c) a
`bout of coughing, and (d) marked changes in the breathing pattern (a deep gasp or yawn). These
`types of artefact and physiological variation should be considered with the measurement protocol
`and subsequent pulse wave analysis.
`
`2.6.2. Pulse wave analysis. Manual measurement and feature extraction techniques were
`often used in the very early days of pulse wave analysis, using various media including
`chart recorder paper and ruler or photographic recording/magnetic tape (e.g. Hertzman and
`Spealman (1937), Dillon and Hertzman (1941), Simonson (1956), Corte (1979), Cooke et al
`(1985), Sherebrin and Sherebrin (1990)). Recent developments in computing technology
`and software data analysis tools have enabled the sophisticated pre- and post-processing
`of physiological waveforms. MATLAB (MathWorks Inc.) is a digital signal processing
`environment that is well suited to pulse wave analysis algorithm prototyping, and often
`appears in the PPG literature.
`It is well established that PPG measurements are quite sensitive to patient and/or probe–
`tissue movement artefact (see examples in figure 5). The automatic detection of such motion
`
`FITBIT, Ex. 1021
`
`

`

`Topical Review
`
`R11
`
`artefact, and its separation from good quality although highly variable pulse recordings,
`is a non-trivial exercise in computer signal processing. Computer-based filtering, feature
`extraction and waveform averaging have also been employed in PPG pulse wave analysis,
`including the analysis of frequency (de Trafford et al 1982, Okada et al 1986, Nitzan et al
`1994, Bernardi et al 1996, Grohmann et al 1996a, 1996b, Larsen et al 1997, Sherebrin
`and Sherebrin 1990), joint-time frequency (Yan et al 2005), artificial neural network (Allen
`and Murray 1993, 1995, 1996, 1999, Weng et al 1998), systems identification and transfer
`function modelling (Cohn et al 1995, Allen and Murray 1993, 1995, 1996, McVeigh et al
`1999, Millasseau et al 2000), principal component analysis (Enr´ıquez et al 2002), nonlinear
`and chaos theory (Christ et al 1997, Bhattacharya et al 2001), cross correlation (Allen and
`Murray 2000a, Drinnan et al 2001) and double differentiation (acceleration plethysmogram,
`Takada et al (1996–97), Takazawa et al (1998), Bortlotto et al (2000)).
`
`3. Clinical applications
`
`PPG has been applied in many different clinical settings, including clinical physiological
`monitoring (blood oxygen saturation, heart rate, blood pressure, cardiac output and
`respiration), vascular assessment
`(arterial disease,
`arterial compliance and ageing,
`endothelial function, venous assessment, vasospastic conditions, e.g. Raynaud’s phenomenon,
`microvascular blood flow and tissue viability) and autonomic function (vasomotor function and
`thermoregulation, blood pressure and heart rate variability, orthostatic intolerance, neurology
`and other cardiovascular variability assessments). This section reviews each of these areas
`with a view to demonstrating the widespread use of the optical technology in medicine and
`also its considerable potential for further innovation and application.
`
`3.1. Clinical physiological monitoring
`
`3.1.1. Blood oxygen saturation. Pulse oximetry is said to represent one of the most significant
`technological advances in clinical patient monitoring over the last few decades (Webster
`1997). It utilizes PPG measurements to obtain information about the arterial blood oxygen
`It has widespread
`saturation (SpO2) as well as heart rate (Aoyagi and Miyasaka 2002).
`application in many different clinical settings, including hospital, outpatient, sports medicine,
`domiciliary use, and in veterinary clinics.
`In the early 1990s pulse oximetry became a
`mandated international standard for monitoring during anaesthesia. An excellent review of
`the technique can be found in Kyriacou (2006) where he described the basic principle of
`operation, measurement technology and its clinical applications. Earlier reviews of pulse
`oximetry have been written by Kelleher (1989) and Severinghaus and Kelleher (1992).
`SpO2 can be determined by shining red and then near infrared light through vascular tissue,
`with rapid switching between the wavelengths. The amplitudes of the red and near infrared
`AC signals are sensitive to changes in SpO2 because of the differences in the light absorption
`of HbO2 and Hb at these two wavelengths. From their amplitude ratio, and corresponding
`PPG DC components, SpO2 can be estimated. This process usually involves an empirically
`derived calibration factor (Webster 1997). There is the assumption that the pulsatile component
`of the PPG signal results solely from the arterial blood volume changes with each heartbeat.
`Limitations of pulse oximetry are that the technique relies upon a peripheral pulse to be present,
`oxygen saturation readings can be affected by dyshaemoglobinaemias, and its accuracy can
`fall off at low saturation levels (Kyriacou 2006). Advanced computer algorithms have been
`developed to try to overcome the problem of movement artefact affecting the measurement
`
`FITBIT, Ex. 1021
`
`

`

`R12
`
`Topical Review
`
`reliability. This includes the Masimo SET technology (Goldman et al 2000, Hayes and Smith
`2001).
`Pulse oximeters can measure SpO2 using both the reflection and transmission modes
`of operation (Mendelson and Ochs 1988). Central body measurement sites have also been
`investigated, including oesophageal oxygen saturation monitoring to overcome the problem of
`finger pulse loss associated with intra-operative peripheral cooling (Kyriacou et al 2002,
`Kyriacou 2006). Another recent and exciting development in pulse oximetry is the non-invasive
`measurement of venous oxygen saturation using external artificial perturbations applied close
`to the PPG probe (VENOX Technology, Chan et al (200

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket